Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Biological Treatment on BP in Arthritis
NCT02132234Phase 4Unknown
- Sponsor
- Jagiellonian University
- Start
- Jun 2013
- Primary completion
- Jul 2014
- Modality
- Antibody Fragments, Polymer-based Nanoparticles, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept, adalimumab, certolizumab pegol, infliximab in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), sponsored by Jagiellonian University. Status: unknown.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02132234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132234.